SOLICITATION NOTICE
B -- Post-Market Bioequivalence of Generic Drug Products
- Notice Date
- 2/21/2024 2:39:52 PM
- Notice Type
- Solicitation
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- FDA CENTER FOR DRUG EVALUATION AND RESEARCH Silver Spring MD 20993 USA
- ZIP Code
- 20993
- Solicitation Number
- Amendment75F40123R00023
- Response Due
- 2/29/2024 7:00:00 AM
- Archive Date
- 03/15/2024
- Point of Contact
- Telisha WIlson
- E-Mail Address
-
telisha.wilson@fda.hhs.gov
(telisha.wilson@fda.hhs.gov)
- Description
- This posting serves as an amendment to Solicitation 75F40124R00023. Q&A were revised, see attached. Proposals are due 10EST 02/29/2024
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/a61cb6f8702d40b99ff72b3cef1de241/view)
- Record
- SN06971781-F 20240223/240221230044 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |